Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Cervical Cancer

Free Subscription Articles published in Cancer Retrieve available abstracts of 30 articles: HTML format

Single Articles

May 2025
1. HUANG CC, Ayala-Peacock DN, Stephens SJ, Chino JP, et al
   Recent advances in gynecologic radiation oncology.
   Cancer. 2025;131:e35888.
   PubMed     Abstract available
   
   
   March 2025
2. BAE HS, Temkin SM
   Cervical cancer stigma - A silent barrier to the elimination of cervical cancer.
   Cancer. 2025;131:e35776.
   PubMed    
   
   
   February 2025
3. PENNINX BMF, Samson MJ, Schnog JB
   Pembrolizumab with chemoradiotherapy followed by pembrolizumab for stage III-IVa cervical cancer: is the ENGOT-cx11/GOG-3047/KEYNOTE-A18 trial practice changing?
   Cancer. 2025;131:e35749.
   PubMed     Abstract available
   
   
   
4. DUSKA LR, Petroni GR, Thaker PH, Crane EK, et al
   Update on safety and feasibility of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer.
   Cancer. 2025;131:e35757.
   PubMed     Abstract available
   
   
   
5. NIERENGARTEN MB
   New standard of care for patients with locally advanced cervical cancer.
   Cancer. 2025;131:e35739.
   PubMed    
   
   
   
6. BAEKER BISPO J, Jemal A, Islami F
   Association of mental health treatment receipt with cancer screening among US adults with a history of anxiety or depression.
   Cancer. 2025;131:e35724.
   PubMed     Abstract available
   
   
   January 2025
7. REN W, Guo X, Liu Z, Wu Y, et al
   Burden of female-specific cancers in China from 1990 to 2021: A systematic analysis for the Global Burden of Disease Study 2021.
   Cancer. 2025;131:e35712.
   PubMed     Abstract available
   
   
   
8. NIERENGARTEN MB
   Overall survival benefit of pembrolizumab plus chemoradiotherapy for patients with high-risk locally advanced cervical cancer.
   Cancer. 2025;131:e35688.
   PubMed    
   
   
   December 2024
9. HENDRIX EL, Chollette VY, Wentzensen N, Loukissas JK, et al
   Federal Cervical Cancer Collaborative: Improving cervical cancer prevention through vaccination, screening, and management in safety-net settings of care.
   Cancer. 2024 Dec 11. doi: 10.1002/cncr.35655.
   PubMed     Abstract available
   
   
   September 2024
10. MEGHANI K, Grover S
    Reply to "Assessing the impact of HIV status on cervical cancer treatment outcomes in Botswana: A commentary".
    Cancer. 2024 Sep 10. doi: 10.1002/cncr.35553.
    PubMed    
    
    
    
11. JEYARAJ G
    Assessing the impact of HIV status on cervical cancer treatment outcomes in Botswana: A commentary.
    Cancer. 2024 Sep 10. doi: 10.1002/cncr.35545.
    PubMed    
    
    
    August 2024
12. ISSAKA RB, Ibekwe LN, Todd KW, Burnett-Hartman AN, et al
    Association between racial residential segregation and screening uptake for colorectal and cervical cancer among Black and White patients in five US health care systems.
    Cancer. 2024 Aug 9. doi: 10.1002/cncr.35514.
    PubMed     Abstract available
    
    
    April 2024
13. DUSKA LR, Podwika SE, Randall LM
    Top advances of the year: Cervical cancer.
    Cancer. 2024 Apr 23. doi: 10.1002/cncr.35334.
    PubMed     Abstract available
    
    
    
14. STERPETTI AV, Gabriele R, Iannone I, Dimarzo L, et al
    National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough.
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35335.
    PubMed    
    
    
    
15. RUAN Y, Heer E, Brenner DR
    Reply to "National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough".
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35339.
    PubMed    
    
    
    
16. NIERENGARTEN MB
    Promising new treatment approaches for locally advanced cervical cancer.
    Cancer. 2024;130:1192.
    PubMed    
    
    
    March 2024
17. MEGHANI K, Puri P, Bazzett-Matabele L, Vuylsteke P, et al
    Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana.
    Cancer. 2024 Mar 26. doi: 10.1002/cncr.35289.
    PubMed     Abstract available
    
    
    
18. LEE H, Baeker Bispo J, Pal Choudhury P, Wiese D, et al
    Factors contributing to differences in cervical cancer screening in rural and urban community health centers.
    Cancer. 2024 Mar 25. doi: 10.1002/cncr.35265.
    PubMed     Abstract available
    
    
    
19. MICHEL AD, Fontenot HB, Fuzzell L, Brownstein NC, et al
    Attitudes toward the American Cancer Society's 2020 cervical cancer screening guidelines: A qualitative study of a national sample of US clinicians.
    Cancer. 2024 Mar 4. doi: 10.1002/cncr.35269.
    PubMed     Abstract available
    
    
    January 2024
20. 
    New test for detecting cervical adenocarcinoma.
    Cancer. 2024;130:10.
    PubMed    
    
    
    
21. BYTNAR JA, McGlynn KA, Nealeigh MD, Shriver CD, et al
    Cancer incidence in the US military: An updated analysis.
    Cancer. 2024;130:96-106.
    PubMed     Abstract available
    
    
    November 2023
22. 
    HPV testing in older women may improve cervical cancer prevention.
    Cancer. 2023;129:3518.
    PubMed    
    
    
    October 2023
23. KNISELY A, Ahmed J, Stephen B, Piha-Paul SA, et al
    Phase 1/2 trial of avelumab combined with utomilumab (4-1BB agonist), PF-04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies.
    Cancer. 2023 Oct 21. doi: 10.1002/cncr.35063.
    PubMed     Abstract available
    
    
    September 2023
24. VADAPARAMPIL ST, Fuzzell LN, Brownstein NC, Fontenot HB, et al
    A cross-sectional survey examining clinician characteristics, practices, and attitudes associated with adoption of the 2019 American Society for Colposcopy and Cervical Pathology risk-based management consensus guidelines.
    Cancer. 2023;129:2671-2684.
    PubMed     Abstract available
    
    
    
25. MACKINNON KM, Risica PM, von Ash T, Scharf AL, et al
    Barriers and motivators to women's cancer screening: A qualitative study of a sample of diverse women.
    Cancer. 2023;129.
    PubMed     Abstract available
    
    
    June 2023
26. FRANCO EL
    The time has come to implement primary human papillomavirus screening for cervical cancer in the United States.
    Cancer. 2023 Jun 22. doi: 10.1002/cncr.34899.
    PubMed    
    
    
    May 2023
27. SPENCER JC, Noel L, Shokar NK, Pignone MP, et al
    Understanding the role of access in Hispanic cancer screening disparities.
    Cancer. 2023;129:1569-1578.
    PubMed     Abstract available
    
    
    April 2023
28. AYALA-PEACOCK DN, Chino JP
    Is it time for bone marrow sparing radiation therapy to be standard of care in cervical cancer?
    Cancer. 2023 Apr 12. doi: 10.1002/cncr.34769.
    PubMed    
    
    
    
29. WANG S, Liu J, Lei K, Jia Y, et al
    Single-photon emission computed tomography-defined active bone marrow-sparing volumetric-modulated arc therapy reduces the incidence of acute hematologic toxicity in locally advanced cervical cancer patients who receive chemoradiotherapy: A single-cen
    Cancer. 2023 Apr 12. doi: 10.1002/cncr.34771.
    PubMed     Abstract available
    
    
    
30. NIERENGARTEN MB
    Balancing the benefits and harms of cervical cancer screening in older women.
    Cancer. 2023;129:979-980.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.